Friday, August 01, 2025 | 03:26 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Sohini Das

Sohini Das

Sohini Das

Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.

Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.

Email
Twitter
LinkedIn

Sohini Das

Tata Motors to raise €1 bn via equity, stake sale to fund Iveco deal

Iveco gets India entry while Tata gains Latin American access

Tata Motors to raise €1 bn via equity, stake sale to fund Iveco deal
Updated On : 01 Aug 2025 | 3:01 AM IST

Daewoo deal helped us understand how to compete: Tata Motors exec

TaMo plans to tap into premium customer segments and cohorts of Iveco which complements its current positioning

Daewoo deal helped us understand how to compete: Tata Motors exec
Updated On : 01 Aug 2025 | 2:27 AM IST

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Trump on Wednesday called India's tariffs on US exports among the highest in the world, with the most strenuous non-monetary trade barriers of any country, in a post on Truth Social

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs
Updated On : 31 Jul 2025 | 5:14 AM IST

M&M Q1 PAT rises 24% to ₹4,083 crore on strong auto volume growth

Auto volumes rise 17 per cent, SUV market share improves 570 bps to 27.3 per cent, while farm and services also report healthy margins and profits in Q1FY26

M&M Q1 PAT rises 24% to ₹4,083 crore on strong auto volume growth
Updated On : 30 Jul 2025 | 11:57 PM IST

Mahindra EV biz posts ₹111 crore Q1 EBITDA, awaits PLI nod for XUV9e

Strong demand for electric SUVs boosts Mahindra's EV business to Rs 111 crore EBITDA in Q1FY26; company awaits PLI certificate and ramps up production gradually

Mahindra EV biz posts ₹111 crore Q1 EBITDA, awaits PLI nod for XUV9e
Updated On : 30 Jul 2025 | 9:19 PM IST

How Wockhardt's bet on multi-drug resistant infections is paying off

In India, Zaynich will be positioned as a third-line treatment, primarily for ICU patients when other antibiotics have failed

How Wockhardt's bet on multi-drug resistant infections is paying off
Updated On : 30 Jul 2025 | 4:52 PM IST

US CDMO business seeing softening, says Piramal Pharma Chairperson

US biotech funding slowdown hits Piramal's CDMO business as company expands sterile injectables facility and maintains long-term growth targets

US CDMO business seeing softening, says Piramal Pharma Chairperson
Updated On : 29 Jul 2025 | 10:56 PM IST

Shailesh Jejurikar becomes first Indian to lead 187-year-old P&G

Chief operating officer of consumer goods conglomerate will succeed Jon Moeller

Shailesh Jejurikar becomes first Indian to lead 187-year-old P&G
Updated On : 29 Jul 2025 | 10:53 PM IST

Battle for ownership brews at Sona BLW after Sunjay Kapur's death

Firm proceeds with AGM despite objections from Kapur's mother

Battle for ownership brews at Sona BLW after Sunjay Kapur's death
Updated On : 25 Jul 2025 | 10:46 PM IST

Govt to closely monitor price hikes of drugs outside essential list

The NPPA will ensure drug companies do not exceed the 10% annual price increase limit on non-essential medicines

Govt to closely monitor price hikes of drugs outside essential list
Updated On : 25 Jul 2025 | 8:32 PM IST

India-UK trade deal: Smooth road ahead as luxury cars set to get cheaper

Under the FTA, tariffs on automotive imports will come down by 50 per cent over 10 years (out of quota)

India-UK trade deal: Smooth road ahead as luxury cars set to get cheaper
Updated On : 25 Jul 2025 | 12:05 AM IST

India-UK trade deal: Med device firms cautious about country of origin

The UK-India Free Trade Agreement is expected to boost trade in pharmaceuticals and medical devices, though industry players remain cautious about the impact of country of origin rules

India-UK trade deal: Med device firms cautious about country of origin
Updated On : 24 Jul 2025 | 11:22 PM IST

Maruti Fronx tops SUV exports in FY25, clocks 100,000 units in 25 months

Fronx drives Maruti Suzuki's record FY25 exports with 69,000 units shipped globally, becoming the fastest SUV to cross 100,000 units in overseas sales

Maruti Fronx tops SUV exports in FY25, clocks 100,000 units in 25 months
Updated On : 24 Jul 2025 | 2:13 PM IST

Renault eyes full capacity at Chennai plant, no new partner planned

In a major product launch from Renault in five years, the company on Wednesday launched a next-generation Triber priced attractively between ₹6.2 lakh and ₹8.4 lakh

Renault eyes full capacity at Chennai plant, no new partner planned
Updated On : 23 Jul 2025 | 7:01 PM IST

Results preview: Pharma firms stare at muted earnings growth for Q1

Hospitals have a steady quarter with occupancies rising 100 bps

Results preview: Pharma firms stare at muted earnings growth for Q1
Updated On : 22 Jul 2025 | 10:49 PM IST

EV giant Tesla's India entry may have more symbolic than strategic value

Many see Tesla's India entry as an attempt to address the capacity glut at its global plants, from where excess inventory might be brought to India

EV giant Tesla's India entry may have more symbolic than strategic value
Updated On : 17 Jul 2025 | 10:51 PM IST

Tesla rolls out Model Y in India, costlier than US, China and Germany

Tesla opens bookings for Model Y in India at up to ₹67.89 lakh due to high import duties, with first deliveries expected later in 2025 from Shanghai plant

Tesla rolls out Model Y in India, costlier than US, China and Germany
Updated On : 15 Jul 2025 | 10:36 PM IST

Q1 results preview: Low volumes, discounts may have dented auto margins

Downside risks from rare-earth magnets an overhang for the sector

Q1 results preview: Low volumes, discounts may have dented auto margins
Updated On : 14 Jul 2025 | 9:13 AM IST

Valuation of Manipal Hospitals hits $13 billion; firm eyes IPO in 2026

Bengaluru-based Manipal Hospitals cements top spot with major expansion, aims IPO

Valuation of Manipal Hospitals hits $13 billion; firm eyes IPO in 2026
Updated On : 11 Jul 2025 | 12:14 AM IST

Glenmark arm inks $700 million licensing deal with US-based AbbVie

IGI Therapeutics, a wholly owned subsidiary of Glenmark, has licensed its cancer and autoimmune drug ISB 2001 to AbbVie for an upfront payment of $700 million

Glenmark arm inks $700 million licensing deal with US-based AbbVie
Updated On : 10 Jul 2025 | 11:21 PM IST